CME β€” CME GROUP INC

Ownership history in Prevatt Capital Ltd  Β·  9 quarters on record

This page tracks every 13F SEC filing in which Prevatt Capital Ltd reported a position in CME GROUP INC (CME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
15.32% (2025 Q2)
πŸ“Š Avg. % of fund
11.18%
πŸ“… First filed
2023 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
9

Position Intelligence

Prevatt Capital Ltd Γ— CME AI Analytics

πŸ“ˆ Prevatt Capital Ltd outperformed the S&P 500 by +1.3% annually on this CME position. Timing score: 67% (2/3 decisions correct). Average cost basis: $217.26. Maximum drawdown during holding period: –8.2%.

πŸ“ˆ Position Alpha vs SPY
+1.3%
annualised excess return

βœ… Outperformed SPY on this position by 1.3% ann.
7 quarters analyzed

⏱️ Timing Score
67%

βœ… Decent timing β€” more right than wrong on entries and exits.
2 of 3 add/trim decisions correct

πŸ’° Entry Quality
$217.26
+22.8% vs current ($266.70)

Best entry: $182.01 (2024 Q2)  Β·  Worst: $266.67 (2025 Q2)

πŸ›‘οΈ Drawdown Resilience
–8.2%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

4 adds Β· 0 trims. Bought during 1 of 2 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
↑ Growing
last 4–5 quarters trend

πŸ“ˆ Prevatt Capital Ltd has been actively increasing its CME allocation β€” a bullish signal from insiders.
Currently 12.8% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CME price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 162,000 β€” 0% 12.80% $44.2M $266.70
2025 Q3 UNCHANGED 162,000 β€” 0% 14.88% $43.8M $262.67
2025 Q2 ADDED 162,000 +12,000 +8.0% 15.32% $44.7M $266.67
2025 Q1 UNCHANGED 150,000 β€” 0% 13.10% $39.8M $255.51
2024 Q4 UNCHANGED 150,000 β€” 0% 10.03% $34.8M $222.57
2024 Q3 ADDED 150,000 +35,000 +30.4% 10.89% $33.1M $205.35
2024 Q2 ADDED 115,000 +5,000 +4.5% 7.05% $22.6M $182.01
2024 Q1 UNCHANGED 110,000 β€” 0% 7.99% $23.7M $198.18
2023 Q4 INITIATED 110,000 β€” β€” 8.56% $23.2M β€”

🏒 Other funds also holding CME

As of 2025 Q4 β€” sorted by position size

Vitol Holding B.V. 3Y 100.0% BP PLC 3Y 7Y 100.0% Kepos Capital LP 3Y 7Y 46.51% GUARDCAP ASSET MANAGEMENT Ltd 3Y 7Y 13.73% CAPITAL COUNSEL LLC/NY 3Y 7Y 8.39% IRON Financial LLC 3Y 7Y 7.33% STEVENS CAPITAL MANAGEMENT LP 3Y 7Y 7.21% Patrick Mauro Investment Advisor, INC. 3Y 7.07% Emmett Investment Management, LP 6.89% CINCINNATI FINANCIAL CORP 3Y 7Y 5.34%
← Back to Prevatt Capital Ltd Holdings